Drug Database
Back to search

Ireland· IE-PA-EU/1/19/1377/001-004

Talzenna 0.25 mg Capsule, hard

A talazoparib product containing talazoparib tosylate, registered in Ireland by Pfizer Europe MA EEIG. The same ATC class is registered in 13 of our 19 countries.

ATC L01XK04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedTalzenna 0.25 mg Capsule, hardATCL01XK04REGISTER NO.IE-PA-EU/1/19/1377/00…PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about talazoparib tosylateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Talazoparib is registered in 13 of 19 countries.

Countries holding a registration under ATC L01XK04 (talazoparib), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose
Search talazoparib products by name

Talazoparib · ATC L01XK04

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of talazoparib costs, country by country.

Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Talazoparib · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$232.73
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
TALAZOPARIB TOSYLATE
Manufacturer
Pfizer Europe MA EEIG
Country
Ireland (IE)
ATC code
L01XK04
ATC class
Talazoparib
Defined daily dose
1 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/19/1377/001-004

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

206 interactions on record for talazoparib.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check talazoparib against other medicinesHow interaction checks work

Talazoparib · interactions on record

206 records

  • 34 severe
  • 172 moderate

Most severe, free to view

  • AmiodaroneC01BD01severe
  • CarvedilolC07AG02severe
  • VerapamilC08DA01severe
  • ClarithromycinJ01FA09severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Talazoparib in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All talazoparib products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Talzenna
  • Iceland · Talzenna
  • Liechtenstein · Talzenna
  • Norway · Talzenna

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4e4a0f5a-a1da-4675-b2bf-e931621022db
GET /v1/drugs/4e4a0f5a-a1da-4675-b2bf-e931621022db?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01XK04"
  ],
  "strength": null,
  "pa_number": "EU/1/19/1377/001-004",
  "substances": [
    "TALAZOPARIB TOSYLATE"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "20/06/2019",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about talazoparib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console